Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

CMS proposes Medicare coverage for T-TEER
CMS has proposed covering tricuspid TEER for patients who present with symptomatic tricuspid regurgitation despite optimal medical therapy. The agency still has questions about the available data, however, and is seeking public comments as it makes its final decision.
Quality of care for heart patients does not improve in first year of ACO participation
Researchers tracked patient outcomes through the use of 15 performance measures related to hypertension, coronary artery disease, heart failure and atrial fibrillation.
Routine interventional procedure may present new endometriosis treatment option
Known to be extremely painful at times, many women with endometriosis consider flare-ups of the condition to be debilitating.
Boston Scientific finalizes Bolt Medical acquisition as FDA clears company’s IVL technology
Boston Scientific hopes to officially launch its new IVL system in the first half of 2026.
Early pregnancy blood pressure patterns tied to hypertension risk years later
Researchers show certain blood pressure patterns during the first 20 weeks of pregnancy were more likely to develop into hypertension later in life.

The premixed injections are available in two different strengths.

Maintaining optimal levels of LDL-C during young adulthood and middle age is one way to limit the risk of coronary heart disease.

Redo TAVR is not always a feasible treatment option, researchers explained. TAVR explantation can be offered to a larger patient population.

Low-income countries were hit especially hard by the pandemic.

Parts of the device can move or become loose during procedures, the FDA warned.

The next-generation devices were designed to be used without blood-thinners.

The Food and Drug Administration has approved booster shots of the Pfizer-BioNTech COVID-19 vaccine.

Pfizer and BioNTech are having trouble finding enough participants to enroll in a study of COVID-19 vaccines in expectant mothers.